2 Promising Vaccines Wait For Approval, Setting Scientific Speed Records

0
29
Biotechnology company Moderna filed Monday for emergency authorization of its coronavirus vaccine, capping a scientific sprint that began in January. Moderna’s two-dose regimen is about a week behind a similar vaccine developed by Pfizer and German biotechnology company BioNTech.

LEAVE A REPLY

Please enter your comment!
Please enter your name here